
RGNT Market Capitalization Overview
Market Cap: $36.98M as of Dec 4, 2025
$36.98M
As of Dec 4, 2025, RGNT has a market capitalization of $36.98M. Over the past 30 days, its market cap has increased by —, while in the last 12 months, it has increased by —.
Market capitalization represents the total value of Regentis Biomaterials Ltd/Israel as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
RGNT Market Cap Formula = Stock Price * Shares Outstanding
The market cap of RGNT helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Regentis Biomaterials Ltd/Israel as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
RGNT Market Cap Formula = Stock Price * Shares Outstanding
The market cap of RGNT helps investors assess the company's size and compare it with competitors for better investment decisions.
RGNT Market Cap & Key Trends
See Regentis Biomaterials Ltd/Israel’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in RGNT
Order type
Buy in
Order amount
Est. shares
0 shares
RGNT Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 3, 2025 | $39.44M | — |
RGNT End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2025 | $36.98M | — |
FAQs About Regentis Biomaterials Ltd/Israel (RGNT) Market Cap
As of Dec 4, 2025, the market capitalization of RGNT is $36.98M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Regentis Biomaterials Ltd/Israel’s market capitalization has increased by —, changing from – to $36.98M as of Dec 4, 2025.
In the last 3 months, Regentis Biomaterials Ltd/Israel’s market capitalization has increased by —, changing from – to – as of –.
In the year –, Regentis Biomaterials Ltd/Israel’s market capitalization increased from – in January to – in December, reflecting a — change.